5-Amino-1MQ
A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that re-activates fat-cell metabolism. Preclinical studies show reduced adiposity and improved metabolic markers without appetite suppression.
Half-life
~6–8 hours
Typical vial
Typically 50–150 mg capsules
Mechanism
Inhibits NNMT in adipocytes, raising intracellular NAD+ and SAM, restoring energy expenditure and lipolysis in metabolically suppressed fat cells.
Research Applications
- Diet-induced obesity models
- Adipose tissue metabolism
- Sarcopenia / muscle aging
Handling & Storage
Store at room temperature, protected from light and moisture. Oral bioavailability — capsule form common.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.